Equibles does not estimate personal net worth.
Get an email with a short summary when Maze Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get MAZE alertsMisbah Tahir is recorded as CFO at Maze Therapeutics, Inc. (MAZE). The newest filing on record that lists Misbah Tahir as CFO at Maze Therapeutics, Inc. (MAZE) is dated April 28, 2026. Maze Therapeutics, Inc. reported in an 8-K filed September 2, 2025 that Misbah Tahir was appointed Chief Financial Officer and "principal financial officer", effective September 2, 2025. Misbah Tahir has spoken on 1 investor event across 1 company, most recently for Maze Therapeutics, Inc. on September 9, 2026. Maze Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Maze Therapeutics, Inc. includes Jason Coloma (CEO and Board Member), Hervé Hoppenot (Chairman and Board Member), Courtney Phillips (General Counsel) and 7 others.
“On September 2, 2025, Maze Therapeutics, Inc. (the "Company") announced that the Board of Directors of the Company (the "Board") appointed Misbah Tahir as the Company's Chief Financial Officer and "principal financial officer," effective as of September 2, 2025 (the "Appointment Date").”
“Sadia, thanks for having us at the conference. It's great and exciting to represent Maze this morning.”
Start not stated–present
Last confirmed April 28, 2026
Biotechnology · Healthcare
CFO
